ESTRO 2024 - Abstract Book

S628

Clinical - Breast

ESTRO 2024

35. Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer. 2005;104(4):856-63.

36. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. British journal of cancer. 2004;91(5):868-72.

37. Overgaard M, Nielsen HM, Tramm T, Højris I, Grantzau TL, Alsner J, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiotherapy and Oncology. 2022;170:4-13.

38. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001;92(6):1411-8.

39. Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, et al. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer. 2005;104(9):1840-8.

40. Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, de Gonzalez AB. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers. Breast cancer research and treatment. 2017;166(1):299-306.

41. Xie L, Bao X, Cai T, Silva SG, Ma J, Zhang Z, et al. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer. International journal of radiation oncology, biology, physics. 2019;105(2):275-84. 42. Xia C, Qin L, Wang Y, Yao L, Shia B, Wu SY. Risk factors and specific cancer types of second primary malignancies in patients with breast cancer receiving adjuvant radiotherapy: a case-control cohort study based on the SEER database. American journal of cancer research. 2022;12(6):2744-56.

43. Li Z, Wang K. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast conserving surgery safe? A nested case-control study. 2020;146(2):352-62.

44. Sun LM, Lin CL, Liang JA, Huang WS, Kao CH. Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study. International journal of cancer. 2015;137(12):2896-903. 45. Marcheselli R, Marcheselli L, Cortesi L, Bari A, Cirilli C, Pozzi S, et al. Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study. Journal of breast cancer. 2015;18(4):378 85.

46. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. Journal of the National Cancer Institute. 1994;86(13):983-8.

47. Snow A, Ring A, Struycken L, Mack W, Koc M, Lang JLE. Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites. Cancer epidemiology. 2021;70.

48. Billena C, Wilgucki M, Flynn J, Modlin L, Tadros A, Razavi P, et al. 10-Year Breast Cancer Outcomes in Women <= 35 Years of Age. International Journal of Radiation Oncology Biology Physics. 2021;109(4):1007-18.